Search research articles
Contact Us
Filters
Showing results (101-110 of 219) with videos related to
Page
of 22
Sort By:
British Journal of Cancer
|
February 7, 2008
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis
R Fruscio, N Colombo, A A Lissoni, et al.
Clinical Neurology and Neurosurgery
|
June 24, 1998
Intracranial hypotension syndrome: neuroimaging in five spontaneous cases and etiopathogenetic correlations
E Ferrante, M Riva, A Gatti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 22, 1998
Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice
G Chiesa, C Parolini, M Canavesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 18, 2014
Optimal treatment of early-stage ovarian cancer
F Collinson, W Qian, R Fossati, et al.
Radiology
|
November 1, 1987
Posterior pituitary gland: appearance on MR images in normal and pathologic states
N Colombo, I Berry, J Kucharczyk, et al.
Gynecologic Oncology
|
March 24, 2021
Corrigendum to 'Comparison between laparoscopy and laparotomy in the surgical re-staging of granulosa cell tumors of the ovary' [Gynecologic Oncology 157 (2020) 85-88]
M Peiretti, G Candotti, M L Fais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2020
The forefront of ovarian cancer therapy: update on PARP inhibitors
M R Mirza, R L Coleman, A González-Martín, et al.
British Journal of Cancer
|
May 20, 2004
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group
A Buda, I Floriani, R Rossi, et al.
Investigational New Drugs
|
August 1, 1990
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer
M D Green, J L Speyer, J C Wernz, et al.
Gynecologic Oncology
|
January 20, 2020
Comparison between laparoscopy and laparotomy in the surgical re-staging of granulosa cell tumors of the ovary
M Peiretti, G Candotti, M L Fais, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 219) with videos related to
Sort By:
Page
of 22
British Journal of Cancer
|
February 7, 2008
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis
R Fruscio, N Colombo, A A Lissoni, et al.
Clinical Neurology and Neurosurgery
|
June 24, 1998
Intracranial hypotension syndrome: neuroimaging in five spontaneous cases and etiopathogenetic correlations
E Ferrante, M Riva, A Gatti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 22, 1998
Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice
G Chiesa, C Parolini, M Canavesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 18, 2014
Optimal treatment of early-stage ovarian cancer
F Collinson, W Qian, R Fossati, et al.
Radiology
|
November 1, 1987
Posterior pituitary gland: appearance on MR images in normal and pathologic states
N Colombo, I Berry, J Kucharczyk, et al.
Gynecologic Oncology
|
March 24, 2021
Corrigendum to 'Comparison between laparoscopy and laparotomy in the surgical re-staging of granulosa cell tumors of the ovary' [Gynecologic Oncology 157 (2020) 85-88]
M Peiretti, G Candotti, M L Fais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2020
The forefront of ovarian cancer therapy: update on PARP inhibitors
M R Mirza, R L Coleman, A González-Martín, et al.
British Journal of Cancer
|
May 20, 2004
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group
A Buda, I Floriani, R Rossi, et al.
Investigational New Drugs
|
August 1, 1990
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer
M D Green, J L Speyer, J C Wernz, et al.
Gynecologic Oncology
|
January 20, 2020
Comparison between laparoscopy and laparotomy in the surgical re-staging of granulosa cell tumors of the ovary
M Peiretti, G Candotti, M L Fais, et al.
Page
of 22